Cardiology Online

Home

Welcome

Scientific Committees

Final Program 

Final Program (as a pdf)

IAC Awards

IAC Distinguished Fellowships

Timetable

Participant Letter

Program Topics

General Information

Writing Instructions &
Sending your Article(s)
to Medimond's Proceeding Book

Instructions for the Preparation of Posters

Registration Form

Accommodation

Exhibition

Exhibitors

Abstract Guidelines

Abstract Form

Contact Us

 

 



     Final Program (as a pdf)

Sunday,
July 27, 2008
Monday,
July 28, 2008
Tuesday,
July 29, 2008
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

Sunday, July 27, 2008

09:00 - 10:15   HALL A
 9:00 OC OPENING CEREMONY
Chairperson:  J.S. Borer, New York, NY, USA

GREETINGS
Asher Kimchi, USA
Founder and Chairman
International Academy of Cardiology
14th World Congress on Heart Disease

Jeffrey S. Borer, USA
Chairman, Scientific Executive Committee
Chairman, Section of Valvular Heart Disease
International Academy of Cardiology
14th World Congress on Heart Disease

John A. Elefteriades, USA
Member, Scientific Executive Committee
Chairman, Section of Cardiovascular Surgery
International Academy of Cardiology
14th World Congress on Heart Disease

Marcos A. Rossi, Brazil
Member, Scientific Executive Committee
Chairman, Section of Vascular Biology 
International Academy of Cardiology
14th World Congress on Heart Disease

Pawan K. Singal, Canada
Member, Scientific Executive Committee
Chairman, Section of Vascular Biology
International Academy of Cardiology
14th World Congress on Heart Disease

PRESENTATION OF 2008 AWARDS
Jeffrey S. Borer, USA

   

 
09:35 - 10:15  OL OPENING LECTURE -
 
THIRD H.J.C. SWAN MEMORIAL LECTURE

Chairperson:  K. Chatterjee, San Francisco, CA, USA
HALL A
09:35 INTRODUCTION
K. Chatterjee, San Francisco, CA, USA
 
09:40

WOMEN AND HEART DISEASE IN THE POST-WHI ERA (Invited Lecture)
E.L. Barrett-Connor, University of California, San Diego, CA, USA

380
10:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 27, 2008
10:45-12:45   HALL A
 

PL:01      Plenary Session
NEW THERAPEUTIC TARGETS IN CARDIOVASCULAR MEDICINE
Chairpersons:  C. Patterson, Chapel Hill, NC, USA
                      S.C. Tyagi, Louisville, KY, USA
 

 
10:45

INHIBITION OF PHOSPHOLIPASES: A NEW STRATEGY TO TREAT ATHEROSCLEROSIS AND ITS CLINICAL COMPLICATIONS? (Invited Lecture)
W. Koenig
, University of Ulm, Ulm, Germany

001
11:00

AN UNAPPRECIATED ROLE FOR UBIQUITIN LIGASES IN EXPERIMENTAL CARDIAC HYPERTROPHY (Invited Lecture) 
C. Patterson
, University of North Carolina, Chapel Hill, NC, USA

002
11:15

RENIN INHIBITION: A NOVEL APPROACH TO BLOOD PRESSURE CONTROL AND ORGAN PROTECTION (Invited Lecture)
A.H.J. Danser
, Erasmus Medical Center, Rotterdam, The Netherlands

004
11:30 CORONARY MICROVASCULAR REGULATION BY ANGIOTENSIN II: PATHOPHYSIOLOGICAL IMPLICATIONS (Invited Lecture)
L. Kuo, T.W. Hein, Texas A&M Health Science Center, Temple, TX, USA
005
11:45 INHIBITING MALONYL COA DECARBOXYLASE AS AN APPROACH TO TREATING ISCHEMIC HEART DISEASE (Invited Lecture)
G.D. Lopaschuk
, University of Alberta, Edmonton, AB, Canada  
006
12:00

CARDIOPROTECTIVE ROLE OF SODIUM THIOSULFATE ON CHRONIC HEART FAILURE BY MODULATING ENDOGENOUS H2S GENERATION (Invited Lecture)
S.C. Tyagi, University of Louisville, Louisville, KY, USA

007
12:15

ROLE OF SARCOPLASMIC RETICULUM IN INCREASING INTRACELLULAR CA2+ DUE TO NA+-K+ ATPASE INHIBITION BY OUABAIN (Invited Lecture)
H.K. Saini-Chohan, N.S. Dhalla, University of Manitoba, Winnipeg, MB, Canada

008
12:30

FINDING AND VALIDATING NEW TARGETS FOR HEART FAILURE TREATMENT (Invited Lecture)
B.C. Blaxall, University of Rochester Medical Center, Rochester, NY, USA

009
12:45 LUNCH BREAK  
SUNDAY, July 27, 2008
10:45-13:00   HALL B
 

 

PL:02       Plenary Session
WHAT’S NEW IN CARDIOMYOPATHIES
Chairpersons: K. Chatterjee, San Francisco, CA, USA
                     M.A. Rossi, Ribeirao Preto, SP, Brazil

 

 

10:45

THE ROLE OF THE INNATE IMMUNE RESPONSE IN PROTECTING AGAINST INFECTION OF THE HEART (Invited Lecture)
N.E. Bowles
, G. Vallejo, University of Utah, Salt Lake City, UT, USA

010
11:00 VINCRISTINE PROTECTS CARDIOMYOCYTES FROM DOXORUBICIN TOXICITY (Invited Lecture)
K. Chatterjee, J. Zhang, R. Tao, N. Honbo, J.S. Karliner, UCSF School of Medicine, San Francisco, CA, USA
011
11:15

CARDIOVASCULAR EFFECTS OF CHRONIC, SUBCLINICAL EXPOSURE TO LIPOPOLYSACCHARIDE (Invited Lecture)
W.Y.W. Lew
, University of California, San Diego, CA, USA

012
11:30

SEPSIS AND THE HEART (Invited Lecture)
M.A. Rossi
, M.R. Celes, D. Torres-Duena, E.C. Campos, C.M. Prado, F.Q. Cunha, University of Sao Paulo, Ribeirao Preto, SP, Brazil

013
11:45

A UNIQUE CLINICAL, GENETIC AND MORPHOLOGICAL FEATURES IN HUMAN MITOCHONDRIAL CARDIOMYOPATHY (Invited Lecture)
T. Toyo-Oka
, H. Hatakeyama, S. Kostin, J. Schaper, Tohoku University, Sendai, Japan

014
12:00 OBESITY AND CONGESTIVE HEART FAILURE (Invited Lecture)    
M.A. Alpert
, University of Missouri, Columbia, MO, USA
015
12:15

DILATED CARDIOMYOPATHY: VARIOUS ETIOLOGIES AND OUTCOME (Invited Lecture)
N.N. Kipshidze
, National Center of Therapy, Tbilisi, Georgia

016
12:30 ANEMIA IN HEART FAILURE (Invited Lecture)
J.N. Nanas, University of Athens, Athens, Greece
017
12:45 TAKO-TSUBO CARDIOMYOPATHY (Invited Lecture)
S.N. Koulouris, Evangelismos Hospital, Athens, Greece
018
13:00 LUNCH BREAK, VISIT POSTERS AND EXHIBITION
SUNDAY, July 27, 2008
10:45 - 13:15   HALL C
 

S21         Session
ACUTE CORONARY SYNDROMES, ACUTE MI, INTERVENTIONAL CARDIOLOGY
Chairpersons:   M.R. Movahed, Tuscon, AZ, USA
                       A.T. Weiss
, Jerusalem, Israel
 

 
10:45

INTRAGRAFT ADMINISTRATION OF ABCIXIMAB AND VERAPAMIL COMBINED WITH DIRECT STENTING PREVENTS SLOW-FLOW AND NO-REFLOW PHENOMENON IN SAPHENOUS VEIN GRAFT PERCUTANEOUS CORONARY INTERVENTION
S. Sharma
, J.A. Lardizabal, A. Antonescu, B. Bhambi, W. Nyitray, K. Desai, T. Ishimori, Bakersfield Heart Hospital, Bakersfield, CA, USA

019
11:00

EARLY INVASIVE THERAPY VERSUS CONSERVATIVE MANAGEMENT IN ACUTE CORONARY SYNDROMES: A LONG-TERM ANALYSIS 
D.J. Kumbhani
, A.A. Bavry, A.N. Rassi, D.L. Bhatt, A.T. Askari, Cleveland Clinic, Cleveland, OH, USA

020
11:15

THE PREDICTOR AND PREDICTIVE VALUE ASSOCIATED WITH DISTAL EMBOLIZATION FOR THE PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION - VIRTUAL HISTOLOGY INTRAVASCULAR ULTRASOUND STUDY
R. Kawaguchi, S. Oshima, H. Hoshizaki, K. Taniguchi, Gunma Prefectural Cardiovascular Center, Maebashi, Japan

021
11:30

LYMPHOPENIA IN ACUTE PHASE OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PREDICTS LONG-TERM REINFARCTION
J. Núñez,
V. Bodí, J. Sanchis, L. Mainar, G. Miñana, P.Merlos, P. Palau, E. Rumiz, E. Núñez, A. Yacer, Universitat de Valencia, Valencia, Spain

022
11:45

ADP-INDUCED PLATELET AGGREGATION FREQUENTLY FAILS TO DETECT IMPAIRED CLOPIDOGREL-RESPONSIVENESS IN PATIENTS WITH CORONARY ARTERY DISEASE COMPARED TO A P2Y12-SPECIFIC ASSAY – INFLUENCE OF LOW HDL
A. Schaefer
, S. Weinberger, G. Ertl, J. Bauersachs, University of Wuerzburg, Wuerzburg, Germany

023
12:00

MECHANISM OF THE REDUCED ASPIRIN ACTION IN PATIENTS AFTER CORONARY ARTERY BY-PASS SURGERY 
T. Mattiello, R. Guerriero, L.V. Lotti, E. Trifiro', B. Pucci, P. Gazzaniga, F. Caporuscio, C .Gaudio, L. Frati, F.M. Pulcinelli, Sapienza University of Rome, Rome, Italy

024
12:15

BACKWARDS INTO THE FUTURE OF MYOCARDIAL REGENERATION
W. Mohl, D. Milasinovic, S. Mina, B. Syeda, G. Weigel, H. Kasahara, K. Komamura, G. Heinze, Medical University of Vienna, Vienna, Austria

025
12:30

CLINICAL UTILITY OF GLUCOSE-INSULIN-POTASSIUM INFUSION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A POOLED META-ANALYSIS OF RANDOMIZED CONTROLLED CLINICAL TRIALS
S.A. Saha, S. Katragadda, J. Molnar, R.R. Arora, Sacred Heart Medical Center, Spokane, WA, USA

026
12:45

PATIENTS WITH ISCHEMIC STROKE, INTRACRANIAL HEMORRHAGE, AND SUBARACHNOID HEMORRHAGE WITH INCREASED TROPONIN I LEVELS HAVE INCREASED HOSPITAL MORTALITY
R. Sandhu, W.S. Aronow, A. Rajdev, R. Sukhija, H. Amin, A. Sangha, New York Medical College, Valhalla, NY, USA

027
13:00

TRANSIENT AND PERSISTENT WORSENING RENAL FUNCTION IN SURVIVORS OF ACUTE MYOCARDIAL INFARCTION TREATED WITH PRIMARY ANGIOPLASTY
A. Goldberg
, H. Hammerman, R. Beyar, M. Kapeliovich, W. Markiewicz, A. Roguin, D. Aronson, Sieff Government Hospital, Safed, Israel, Cardiology 

028
13:15 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, July 27, 2008
10:45 - 12:30   HALL D
 

S22       Session
ATHEROSCLEROSIS: PRIMARY PREVENTION, HYPERTENSION, DIABETES MELLITUS, OBESITY, METABOLIC SYNDROME
Chairpersons:   S.S. Franklin, Irvine, CA, USA
                       D. Polk
, Los Angeles, CA, USA
 

 
10:45

STATIN PLUS CHOLESTEROL ABSORPTION INHIBITION GIVES GREATER LDL
F.F. Samaha, N. Iqbal, D. Bregman, H. Ashfaq, M.M. Williams,
University of Pennsylvania, Philadelphia, PA, USA

030
11:00

THE PRESENCE OF OBESITY IS STRONGLY ASSOCIATED WITH ESSENTIAL HYPERTENSION
M.R. Movahed, M. Jamal, M. Hashemzadeh, University of Arizona Sarver Heart Center, Southern Arizona VA Health Care System, Tucson, AZ, USA

031
11:15

IMPACT OF OBESITY ON MEASURES OF MORBIDITY AND MORTALITY IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING
M. Alam, S.S. Virani, V. Nambi, V. Lee, M. Elayda, J.M. Wilson, C.M. Ballantyne, Baylor College of Medicine, Houston, Texas, USA

032
11:30

EFFECT OF REDUCTION OF IRON STORES ON VASCULAR AND CANCER OUTCOMES IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD): VA COOPERATIVE STUDY #410, THE IRON AND ATHEROSCLEROSIS STUDY (FEAST)
L.R. Zacharski, B.K. Chow, G.Shamayeva, P.W. Lavori, VA Medical Center, White River Jct., VT, Dartmouth Medical School, Lebanon, NH, USA

033
11:45

IMPACT OF COMPUTERIZED DECISION SUPPORT ON BLOOD PRESSURE MANAGEMENT AND CONTROL: A RANDOMIZED CONTROLLED TRIAL
L.S. Hicks, T. D. Sequist, J.Z. Ayanian, S. Shaykevich, D.F. Fairchild, E.J. Orav, D.W. Bates, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

036
12:00 ALDOSTERONE-TO-RENIN RATIO, INDEPENDENTLY PREDICTS BLOOD PRESSURE IN A POPULATION OF AFRICAN ANCESTRY
A.J. Woodiwiss
, D.G.A. Veliotes, L. Scott, O.H.I. Majane, M.J. Maseko, J. Paiker, N. Crowther, P. Dessein, P. Sareli, G.R. Norton, University of the Witwatersrand, Johannesburg, South Africa
037
12:15 OVERALL NUTRITIONAL QUALITY INDEX (ONQI): A CONSUMER GUIDANCE SYSTEM 
D.L. Katz, V.Y. Njike, Z. Faridi, L.Q. Rhee,
K-T. Ayoob, Yale School of Medicine, Derby, CT, USA
038
12:30 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, July 27, 2008
14:00 - 16:30   HALL A
 

PL:03        Plenary Session
ARRHYTHMIA AND ELECTROPHYSIOLOGY/ CARDIAC PACING AND DEFIBRILLATION/CARDIAC RESYNCHRONIZATION THERAPY
Chairpersons:  M.E. Cain, Buffalo, NY, USA   
                     
S.F. Nagueh
, Houston, TX, USA

 

 
14:00 ROLE OF PSYCHOLOGICAL FACTORS IN TRIGGERING OF ARRHYTHMIAS (Invited Lecture)
R. Lampert, Yale School of Medicine, New Haven, CT, USA
084
14:15

IMPACT OF NONINVASIVE TESTING ON IMPROVING IDENTIFICATION OF PATIENTS VULNERABLE TO SUSTAINED VENTRICULAR ARRHYTHMIAS (Invited Lecture)
M.E. Cain, University at Buffalo, Buffalo, NY, USA

085
14:30

CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE PATIENTS: HOW TO PREDICT RESPONDERS (Invited Lecture)
M.H. Pitzalis, East Carolina University, Greenville, NC, USA

086
14:45

DYSSYNCHRONY IN DIASTOLIC HEART FAILURE (Invited Lecture)
S.F. Nagueh, Methodist De Bakery Heart and Vascular Institute, TX, USA

087
15:00

HOW TO SELECT THE APPROPRIATE CANDIDATES FOR CARDIAC RESYNCHRONIZATION THERAPY (Invited Lecture)
M. Haghjoo, Iran University of Medical Sciences, Tehran, Iran

088
15:15

PSYCHOSOCIAL ADAPTATION AND QUALITY-OF-LIFE IN PATIENTS WITH PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS (Invited Lecture)
F. Duru, University Hospital of Zurich, Zurich, Switzerland

089
15:30

CLINICAL CHARACTERISTICS AND RISK STRATIFICATION IN BRUGADA SYNDROME (Invited Lecture)
M. Takagi, Y. Sekiguchi, Y. Yokoyama, N. Aihara, K. Aonuma, M. Hiraoka, Osaka City University, Osaka, Japan

090
15:45

AN ATHLETE'S HEART MAY HARBOUR PROARRHYTHMIC CHANGES (Invited Lecture)
H. Heidbuchel, University of Leuven, Leuven, Belgium           

091
16:00

Long QT Syndrome: Should an ICD be Used? (Invited Lecture)
J.P. Daubert, University of Rochester Medical Center, Rochester, NY, USA          

092
16:15

UPDATE IN SYNCOPE MANAGEMENT. APPLICATIONS OF THE NEW GUIDELINES (Invited Lecture)
D. Flammang, La Croix Rousse University Hospital, Lyon, France       

093
16:30 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, July 27, 2008
14:00 - 16:00   HALL B
  PL:0   Plenary Session
NEW DEVELOPMENTS IN CARDIAC IMAGING
Chairperson  A.H. Jansen, Nijmegen, The Netherlands
                   
R. Krittayaphong, Bangkok, Thailand
                       
  
 
14:00 CLINICAL APPLICATION OF 3D ECHO (Invited Lecture)
T. Shiota, The Cleveland Clinic Foundation, Cleveland, OH, USA
094
14:15 ATHEROSCLEROSIS IMAGING: A CT/MR PERSPECTIVE (Invited Lecture)
S. Rajagopalan, Ohio State University, Columbus, OH, USA          
095
14:30

DIAGNOSTIC AND PROGNOSTIC VALUE OF ECG CRITERIA FOR MYOCARDIAL INFARCTION IN COMPARISON WITH DELAYED-ENHANCEMENT MAGNETIC RESONANCE IMAGING (Invited Lecture)
R. Krittayaphong, Siriraj Hospital, Mahidol University, Bangkok, Thailand       

096
14:45

RISK STRATIFICATION WITH STRESS ECHOCARDIOGRAPHY (Invited Lecture)
A. Elhendy,
Marshfield, WI, USA      

097
15:00

PROGNOSTIC VALUE OF CARDIOVASCULAR MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ISCHEMIC HEART DISEASE (Invited Lecture)
V. Bodi,
Hospital Clinico Universitario, Valencia, Spain

099
15:15

NEW ASPECTS OF ULTRASOUND CONTRAST IN CARDIOLOGY (Invited Lecture)
A.H. Jansen, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands

100
15:30

NON-INVASIVE ASSESSMENT OF VASCULAR LOAD AND VENTRICULAR-VASCULAR COUPLING: A FOCUS ON ECHOCARDIOGRAPHY (Invited Lecture)
J.A. Chirinos, University of Pennsylvania, VA Medical Center, Philadelphia, PA, USA

101
15:45

COMPARISON OF CARDIAC MDCT AND TEE IN DETECTING HIGH RISK EMBOLIC SOURCES
S.B. Ko, Y. Ko, J.H. Park, S.I Choi, EJ Chun, S.J Lee, M.K Han, H.J. Bae,
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea

102
16:00 COFFEE BREAK, VISIT POSTERS & EXHIBITION
SUNDAY, July 27, 2008
14:00 - 15:45   HALL C
 

S23        Session
SECONDARY PREVENTION, MODIFICATION OF   LIPOPROTEINS, PROGNOSIS, RISK STRATIFICATION
Chairpersons:    Y. Birnbaum, Galveston, TX, USA
                        C.J. Chen
, Houston, TX, USA

 
14:00

OMEGA-3-ACID ETHYL ESTERS REDUCES SMALL DENSE LOW DENSITY LIPOPROTEINS REGARDLESS OF THE BASELINE LIPID PROFILE
S.M. Attia, K.H. Nader, Tanta University, Tanta, Egypt

103
14:!5

INADEQUATE ATTAINMENT OF RECOMMENDED LIPID LEVELS IN TREATED PATIENTS
G.A. Nichols, B.M. Ambegaonkar, V. Sazonov, J.B. Brown, Kaiser Permanente Center for Health Research, Portland, OR, USA

104
14:30

PROGNOSTIC SIGNIFICANCE OF INCIDENT COMPLETE LEFT BUNDLE BRANCH BLOCK OBSERVED OVER A 40-YEAR PERIOD
S. Seto, R. Imanishi, S. Ichimaru, E. Nakashima, M. Akahoshi, Nagasaki University, Nagasaki, Japan

106
14:45

IMPAIRED GLUCOSE TOLERANCE STRONGLY AND SIGNIFICANTLY INCREASES THE RISK OF FUTURE VASCULAR EVENTS IN ANGIOGRAPHIED CORONARY PATIENTS
H. Sourij, C.H. Saely, S. Aczel, H. Jahnel, R. Zweiker, T. Marte, G. Hoefle, W. Benzer, T.C. Wascher, H. Drexel,
VIVIT Institute, Feldkirch, Austria

107
15:00

A SIMPLE PROGNOSTIC CLASSIFICATION MODEL FOR POST-PROCEDURAL COMPLICATIONS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE MYOCARDIAL INFARCTION: RESULT BASED ON NEW YORK STATE PERCUTANEOUS CORONARY INTERVENTION DATABASE
A. Negassa, Albert Einstein College of Medicine, New York, USA

109
15:15

EFFECT OF ONCE WEEKLY ROSUVASTATIN ON LDL-C IN PATIENTS WITH PRIOR STATIN INTOLERANCE
J.M. Backes
, J.F. Ruisinger, C.A. Gibson, P.M. Moriarty, Kansas University Medical Center (KUMC), Kansas City, KS, USA

110
15:30

HDL MORE THAN LDL: AN ACHIEVABLE GOAL: A CLINICAL EXPERIENCE
K.J. Reddy, J.R. Bangit, M.S. Zaheer, M. Singh, R.R. Batsell, A.Z. Khan,
Reddy Cardiac Wellness, Sugar Land, TX, USA

111
15:45 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, July 27, 2008
14:00 - 17:00   HALL D
 

S24       Session
VASCULAR BIOLOGY, BASIC RESEARCH

Chairpersons:    S.B. Wheatcroft, Leeds, UK
                        P.K. Singal, Winnipeg, MB, Canada
 

 
14:00

OVEREXPRESSION OF CU/ZN-SUPEROXIDE DISMUTASE AND/OR CATALASE REDUCES BENZO(A)PYRENE-INDUCED ATHEROSCLEROSIS IN APOLIPOPROTEIN E-DEFICIENT MICE
Z. Guo, Meharry Medical College, TN, USA

112
14:15

THE ANGIOPOIETIN I +1602 A/T POLYMORPHISM ATTENUATES MICRORNA BINDING AND INCREASES RISK OF HEMORRHAGIC STROKE 
T. Yang, J. Chen, S. Yi, K. Sun, R.T. Hui, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China

113
14:30

THE CX3C CHEMOKINE FRACTALKINE ENHANCES VASCULAR DYSFUNCTION AND AGGRAVATES PLATELET ACTIVATION IN RATS WITH CHRONIC HEART FAILURE
A. Schaefer, C. Schulz, D. Fraccarollo, C. Schoepp, J.P. Frang, G. Ertl, S. Massberg, J. Bauersachs, University of Wuerzburg, Wuerzburg, Germany

114
14:45

CD40L IS UP-REGULATED BY TUMOR NECROSIS FACTOR IN PATIENTS WITH HEART FAILURE
P. Pignatelli, F. Violi, University of Rome La Sapienza, Rome, Italy

115
15:00

APOLIPOPROTEIN E-DEFICIENT LIPOPROTEINS INDUCE FOAM CELL FORMATION BY ACTIVATION OF UNFOLDED PROTEIN RESPONSES
H. Yang, Z. Guo, Meharry Medical College, TN, USA

116
15:15

THE EFFECTS OF RIVAROXABAN – AN ORAL, DIRECT FACTOR XA INHIBITOR – ON CLOT STRUCTURE AND DEGRADABILITY 
R. Varin, S. Mirshahi, P. Mirshahi, H. Li, G. Kierzek, J.F. Vigneau, E. Perzborn, M. Mirshahi, C. Soria, J. Soria,  
Centre de Recherche des Cordeliers, Paris, France

117
15:30

DIFFERENCES BETWEEN NEW AND CLASSIC INTRAVENOUS IRON PREPARATIONS ON CARDIOVASCULAR TOXICITY IN NORMAL RATS
J.E. Toblli, G. Cao, L. Oliveri, M. Angerosa, Hospital Alemán, Buenos Aires, Argentina  

118
15:45

SYSTEMIC AND REGIONAL HEMODYNAMICS OF HYPOXIC PIGLETS TREATED WITH NG-MONOMETHYL-L-ARGININE AFTER RESUSCITATION
T.F. Lee, C. Tymafichuk, P.Y. Cheung, University of Alberta, Edmonton, AB, Canada

119
16:00

ORAL L-ARGININE IS A REPAIRMAN BUT NOT AN ENHANCER OF ENDOTHELIAL FUNCTION: SYSTEMATIC REVIEW AND META-ANALYSIS
Y.Y. Bai, L. Sun, T. Yang, K. Sun, J.Z. Chen, R.T. Hui, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China

120
16:15

DIFFERENTIAL EXPRESSION OF FRACTALKINE AND MONONUCLEAR CELL RECRUITMENT BY HUMAN ARTERIAL OR VEIN ENDOTHELIAL CELLS STIMULATED WITH ANGIOTENSIN-II
M. Losada, L. Piqueras, C. Lopez-Gines, C. Company, C. Rius, M.J. Sanz, University of Valencia, Valencia, Spain

121
16:30

INTERLEUKIN-18 (IL-18), ENDOTHLINE-1 AND ALDOSTERONE INDUCE SMOOTH MUSCLE SENESCENCE VIA RHO-KINASE- AND PPAR- DEPENDENT PATHWAY
T. Akagami, T. Sakoda, T. Doi, T. Naka, T. Tsujino, T. Masuyama, M. Ohyanagi, Hyogo College of Medicine, Hyogo Japan

122
16:45

CHLAMYDIA INFECTION IN CARDIOVASCULAR PATHOLOGY: SEQUEL II
I.M. Petyaev, N.A. Zigangirova, Cambridge Theranostics Ltd., Cambridge, UK

123
17:00 COFFEE BREAK, VISIT POSTERS & EXHIBITION
SUNDAY, July 27, 2008
16:45-19:15   HALL A
 

PL:05        Plenary Session
THE RELEVANCE OF GENETICS IN PROVIDING AN
UNDERSTANDING OF CARDIOVASCULAR DISEASES
Chairpersons:     H. Boudoulas, Athens, Greece
                         K. Maiese, Detroit, MI, USA
 

 
16:45

GENETICS OF CORONARY ARTERY DISEASE IN FAMILIES (Invited Lecture)
L.C. Becker, D.M. Becker, Johns Hopkins University, Baltimore, MD, USA

124
17:00

GENETICS OF MYOCARDIAL INFARCTION (Invited Lecture)
R. Roberts, University of Ottawa Heart Institute, Ottawa, ON, Canada

125
17:15

GETTING TO THE POINT: FORKHEAD TRANSCRIPTION FACTORS IN THE VASCULAR SYSTEM (Invited Lecture)
K. Maiese, Wayne State University, Detroit, MI, USA

126
17:30

PHARMACOGENETICS AND PHARMACOGENOMICS IN CARDIOLOGY (Invited Lecture)
H. Boudoulas, Biomedical Research Foundation, Ohio State University, Academy of Athens, Athens, Greece

127
17:45

GENETICS AND METABOLIC RISK OF ATHEROSCLEROSIS (Invited Lecture)
R.A. Hegele, University of Western Ontario, London, ON, Canada

128
18:00

IDENTIFICATION OF MI-SUSCEPTIBILITY GENES USING GENOME-WIDE LINKAGE ANALYSIS (Invited Lecture)
M. Yokota, H. Asano, S. Miyata, M. Nakatochi, M. Sukegawa, H. Izawa, Aichi-Gakuin University, Nagoya, Japan

129
18:15

DE-REGULATED EXPRESSION OF E2F-1 INCREASES BNIP3 AND CELL DEATH OF VENTRICULAR MYOCYTES DURING HYPOXIA (Invited Lecture)
J. Shaw, N. Yurkova, L.A. Kirshenbaum,
St. Boniface General Hospital Research Centre, Winnipeg, MB, Canada

130
18:30

GENE-TARGETING OF NATRIURETIC PEPTIDE RECEPTOR-A REVEALS ITS ROLE IN CARDIAC HYPERTROPHY (Invited Lecture)
K.N. Pandey, Tulane University, New Orleans, LA, USA  

131
18:45

DNAZYMES IN THE TREATMENT OF CARDIOVASCULAR DISEASE (Invited Lecture)
V.L. Benson, L.M. Khachigian, H.C. Lowe, Concord Repatriation General Hospital, NSW, Australia

132
19:00

ROLE OF PHOSPHOLIPASE C IN CARDIAC HYPERTROPHY (Invited Lecture)
P.S. Tappia, University of Manitoba, Winnipeg, MB, Canada

133
SUNDAY, July 27, 2008
16:45 - 19:15    
 

PL:06       Plenary Session
MODIFICATION OF RISK FACTORS AND CAD, DYSLIPOPROTEINEMIA, HYPERTENSION, DIABETES MELLITUS AND METABOLIC SYNDROME
Chairpersons:   G.S. Berenson, New Orleans, LA, USA
                       C. Rosendorff
, New York, NY, USA
 

 
16:450

A GUIDE TO THE NEW GUIDELINES FOR THE MANAGEMENT OF HYPERTENSION (Invited Lecture)
C. Rosendorff,
Mount Sinai School of Medicine, New York, NY, USA

134
17:00

METABOLIC SYNDROME IN CHILDHOOD AND ITS IMPACT ON ADULT HEART DISEASE: THE BOGALUSA HEART STUDY (Invited Lecture)
G.S. Berenson, Tulane University, New Orleans, LA, USA

135
17:15

PULSE PRESSURE, DIASTOLIC BLOOD PRESSURE AND THE J-CURVE OF CARDIOVASCULAR DISEASE RISK (Invited Lecture)
S.S. Franklin, University of California, Irvine, CA, USA

136
17:30

PROTEIN KINASE A REGULATES APOLIPOPROTEIN E SECRETION BY MACROPHAGES (Invited Lecture)
L. Kritharides, University of Sydney, Sydney, NSW, Australia

138
17:45

HIV PROTEASE INHIBITOR RITONAVIR INHIBITS CHOLESTEROL EFFLUX FROM HUMAN MACROPHAGE-DERIVED FOAM CELLS (Invited Lecture)
C. Chen, X. Wang, H. Mu, H. Chai, D. Liao, Q. Yao, Baylor College of Medicine, Houston, TX, USA

139
18:00

DIETARY STRATEGIES FOR HYPERTENSION PREVENTION: PROGRESS AND PROMISE (Invited Lecture)
H.D. Sesso, Brigham & Women's Hospital, Boston, MA, USA

140
18:15

INTENSIVE STATIN THERAPY IN CHD - A REVIEW OF THE EVIDENCE (Invited Lecture)
K.K. Ray, University of Cambridge, Cambridge, England

141
18:30

COMBINATION THERAPY IN LIPID MANAGEMENT (Invited Lecture)
D. Polk, Cedars-Sinai Medical Center, Los Angeles, CA, USA

142
18:45

RETROSPECTIVE ANALYSIS OF LIPIDS PROFILE IN A CARDIOLOGY PRACTICE (Invited Lecture)
Y. Charuzi, J. Mirocha, T.W. Lang, Cedars Sinai Medical Center, Los Angeles, CA, USA

143
SUNDAY, July 27, 2008
16:45 - 19:30   HALL C
 

S25         Session
ARRHYTHMIAS I: SUDDEN CARDIAC DEATH / IMPLANTABLE ANTIARRHYTHMIC DEVICES / PACING / CRT
Chairpersons:     R. Lampert, New Haven, CT, USA
                         P. Whittaker, Worcester, MA, USA
 

 
16:45

STRONG INDEPENDENT ASSOCIATION BETWEEN TYPE 2 DIABETES MELLITUS AND THIRD DEGREE AV-BLOCK
M.R. Movahed, M. Hashemzadeh, Southern Arizona VA, Health Care System, University of Arizona, Tucson, AZ, USA

145
17:00

HIGH INCIDENCE OF RADIOTHERAPY-INDUCED MALFUNCTION OF PERMANENT PACEMAKERS AND ICDS: A SINGLE CENTER EXPERIENCE
D.W. Ng, F.J. Tondato, G.A. Ezzell, D. Sorajja, E. Wissner, K. Srivathsan, G.T. Altemose, M.Y. Halyard, L.R. Scott, Mayo Clinic Arizona, Scottsdale, AZ, USA

146
17:15

PRECORDIAL T-PEAK DISPERSION IS GREATER IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK THAN IN PATIENTS WITH RIGHT BUNDLE BRANCH BLOCK OR NARROW QRS: A NOVEL MARKER OF DYSSYNCHRONY?
G.Mark, S. Natan, E.Rhim, A.J.Greenspon, R.T. Ho, B.B. Pavri, Cooper University Hospital, Camden, NJ, USA

147
17:30

ECHOCARDIOGRAPHY TO PREDICT LONG-TERM REVERSE REMODELING AFTER CARDIAC RESYNCHRONIZATION THERAPY; VALUE OF QUALITATIVE OBSERVATION
A.H.M. Jansen, F. Bracke, J.M. van Dantzig, A. Meijer, C.H. Peels, P.H. van der Voort, H.H.M. Korsten, N.M. van Hemel, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands

148
17:45

SURVIVAL IS SIMILAR AFTER STANDARD TREATMENT AND CHEST COMPRESSION ONLY IN OUT-OF-HOSPITAL BYSTANDER CARDIOPULMONARY RESUSCITATION
K.E. Bohm, M. Rosenqvist, J. Herlitz, J. Hollenberg, L. Svensson, Karolinska Institutet, Sodersjukhuset, Stockholm, Sweden

150
18:00

DOES SEVERITY OF SLEEP APNEA CORRELATE WITH RISK OF ARRHYTHMIC DEATH?
A.Q. Chan, E.L. Lua, M.P. Chan, Stanford University, Stanford, CA, USA

151
18:15

VALUE OF ROUTINE DFT TESTING AT TIME OF ICD PULSE GENERATOR REPLACEMENT
M. Singh, J. Akar,  J. Cytron, N. Varma, D. Wilber, P. Santucci, Loyola University, Maywood, IL, USA

152
18:30

PREVALENCE OF APPROPRIATE CARDIOVERTER-DEFIBRILLATOR SHOCKS IN 1,038 CONSECUTIVE PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
A. Kruger, W.S. Aronow, H.M. Lai, H. Desai, A. Singla, W.H. Frishman, M. Cohen, C. Sorbera, New York Medical College, Valhalla, NY, USA

153
18:45

OUTCOMES AND COST ANALYSIS OF TRANSVENOUS VS PROPHYLACTIC INTRAOPERATIVE IMPLANTATION OF CRT LEADS (PROPEL STUDY)
M. Biria, E. Baryun, J. Vacek, K. Dalton, M. Earnest, M. Emert, R. Pimentel, D. Lakkireddy, L. Berenbom, University of Kansas Hospital, Kansas City, KS, USA

155
19:00

INCIDENCE OF MORTALITY IN 1,040 PATIENTS WITH CARDIOVASCULAR DISEASE WITH NORMAL AND ABNORMAL QRS DURATION AND WITH NORMAL AND ABNORMAL LEFT VENTRICULAR EJECTION FRACTION
H.M. Lai, W.S. Aronow, A. Rajdev, A. Asija, K.V. Lai, J. George, J.A. McClung, New York Medical College, Valhalla, NY, USA

156
19:15

PREVALENCE AND PROGNOSIS FOR SYNCOPE AMONG CARDIAC TRANSPLANT RECIPIENTS
M.A. Caccamo, D.J. Cantillon, E.Z. Gorodeski, W. Saliba, B.L. Wilkoff, R.C. Starling, Cleveland Clinic Foundation, Cleveland, OH, USA

157
SUNDAY, July 27, 2008
16:45 - 19:00   HALL D
 

S26          Session
INTERVENTIONAL CARDIOLOGY II
Chairpersons: F. Dagenais, Quebec, QC, Canada
                  
  H. Mudra, München, Germany
 

 
16:45

RECURRENT REVASCULARIZATION AFTER IMPLANTATION OF DRUG ELUTING STENTS: RESTENOSIS OR PROGRESSION OF ATHEROSCLEROTIC DISEASE
M. Fineschi, T. Gori, Hospital of Siena, Siena, Italy

158
17:00 MINIMALLY INVASIVE MITRAL SURGERY: SHOULD IT BE CONSIDERED STATE OF THE ART FOR ISOLATED MITRAL DISEASE? (Invited Lecture)
F. Dagenais, Laval Hospital, Quebec, QC, Canada
167
17:15

CONTRAST-INDUCED NEPHROPATHY AFTER LOW - OR ISO-OSMOLAR CONTRAST MEDIA USE IN HIGH RISK PATIENTS: DATA FROM THE CARE TRIAL
A. Moreyra, J. Reiner, C.S. Staniloae, S.K. Sharma, R.E. Katholi, R.J. Solomon, University of Medicine and Dentistry, New Brunswick, NJ, USA

160
17:30

DO DISTAL EMBOLIC PROTECTION DEVICES IMPROVE OUTCOMES OF PERCUTANEOUS TREATMENT OF SAPHENOUS VEIN GRAFT LESIONS?
A.A. Hilliard, R.J. Lennon, L.N. Hammes, C.S. Rihal, D.R. Holmes, V. Mathew, Mayo Clinic, Rochester, MN, USA

161
17:45

A RANDOMIZED COMPARISON OF PACLITAXEL-ELUTING STENTS VERSUS BARE-METAL STENTS FOR TREATMENT OF UNPROTECTED LEFT MAIN CORONARY ARTERY STENOSIS: LONG TERM FOLLOW-UP
A. Erglis, I. Narbute, S. Jegere, I. Kumsars, K. Trusinskis, Latvian Centre of Cardiology, Riga, Latvia

162
18:00

CAROTID STENTING IN SYMPTOMATIC VS. ASYMPTOMATIC PATIENTS - SINGLE CENTER EXPERIENCE FROM 600 CONSECUTIVE CAROTID INTERVENTIONS WITH NEUROPROTECTION
R. Hein, F. Beier, M. Hug, H. Strohm, H. Mudra, Städtisches Klinikum Muenchen GmbH, Klinikum Neuperlach, Munich, Germany

163
18:15

PERCUTANEOUS CORONARY INTERVENTION IN OCTOGENARIANS: AN OUTCOME ANALYSIS
A.K. Kondur, A. Niraj, J. Pradhan, V. Veeranna, H. Fakhry, L. Afonso,
Wayne State University, Detroit, MI, USA

165
18:30

ANACONDA ENDOVASCULAR LIMBS FOR TREATMENT OF POPLITEAL ARTERY ANEURYSMS
T. Rapanos, R. Moore, C.S. Cina, McMaster University, Hamilton, ON, Canada

166